Qimin Wu
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Adenosine and Purinergic Signaling, Synthesis of β-Lactam Compounds, Antiplatelet Therapy and Cardiovascular Diseases, Heart Failure Treatment and Management, Carbohydrate Chemistry and Synthesis
Most-Cited Works
- → Conformationally Constrained ortho-Anilino Diaryl Ureas: Discovery of 1-(2-(1′-Neopentylspiro[indoline-3,4′-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a Potent, Selective, and Bioavailable P2Y1 Antagonist(2013)69 cited
- → Discovery of 2-(Phenoxypyridine)-3-phenylureas as Small Molecule P2Y1 Antagonists(2013)58 cited
- → New azole antagonists with high affinity for the P2Y1 receptor(2013)25 cited
- → 2-Aminothiazole based P2Y1 antagonists as novel antiplatelet agents(2013)24 cited
- → Discovery of diarylurea P2Y1 antagonists with improved aqueous solubility(2013)19 cited
- → The identification and characterization of hydrazinyl urea-based antibacterial agents through combinatorial chemistry(2001)13 cited
- → 2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists(2014)11 cited
- → Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds(2013)10 cited